Bio-Techne
TECH
#1510
Rank
NZ$20.52 B
Marketcap
$129.18
Share price
1.29%
Change (1 day)
8.94%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$3.79 Billion

According to Bio-Techne's latest financial reports the company has NZ$3.79 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$NZ$3.24 B18.63%
2022-06-30$NZ$2.73 B21.56%
2021-06-30$NZ$2.24 B4.61%
2020-06-30$NZ$2.14 B23.93%
2019-06-30$NZ$1.73 B8.82%
2018-06-30$NZ$1.59 B22.65%
2017-06-30$NZ$1.29 B5.26%
2016-06-30$NZ$1.23 B-0.33%
2015-06-30$NZ$1.23 B36.66%
2014-06-30$NZ$0.90 B-4.86%
2013-06-30$NZ$0.95 B13.33%
2012-06-30$NZ$0.84 B18.46%
2011-06-30$NZ$0.70 B-3.08%
2010-06-30$NZ$0.73 B3.56%
2009-06-30$NZ$0.70 B10.56%
2008-06-30$NZ$0.63 B12.31%
2007-06-30$NZ$0.56 B2.04%
2006-06-30$NZ$0.55 B45.16%
2005-06-30$NZ$0.38 B-18.03%
2004-06-30$NZ$0.46 B15.37%
2003-06-30$NZ$0.40 B-4.36%
2002-06-30$NZ$0.42 B-2.76%
2001-06-30$NZ$0.43 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$87.17 B 2,195.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.29 B 250.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$45.96 B 1,110.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$91.08 B 2,298.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.26 B 65.06%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$33.91 B 793.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$84.61 M-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA